Insider Holders & Insider Ownership - ENZO BIOCHEM INC (ENZ)

List of insiders holdings for ENZO BIOCHEM INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
HARBERT MANAGEMENT CORP
Harbert Discovery Fund LP
HARBERT DISCOVERY FUND GP LLC
HARBERT DISCOVERY CO-INVESTMENT FUND I LP
HARBERT DISCOVERY CO-INVESTMENT FUND I GP LLC
HARBERT FUND ADVISORS INC.
BRYANT JOHN F.
LUCAS KENAN
HARBERT RAYMOND J
10% Owner
2021-10-28 16:39:475,175,913
0
5,175,913Form 13D
Radoff Bradley Louis
Director
2024-02-02 21:00:564,390,882
430,000
4,820,882Form 4
Wolf James G.
10% owner until 2/13/2023
2023-02-13 21:41:294,103,970
423,500
4,527,470Form 4
RABBANI ELAZAR
CHIEF EXECUTIVE OFFICER
2021-01-13 21:40:522,262,208
0
2,262,208Form 4
WEINER BARRY W
PRESIDENT AND TREASURER
2021-01-13 21:44:011,657,499
0
1,657,499Form 4
RABBANI SHAHRAM K
Treasurer, Secretary
2009-07-06 17:28:251,622,037
0
1,622,037Form 4
Erfanian Hamid
Chief Executive Officer
2022-11-28 18:27:581,374,600
0
1,374,600Form 4
Cannon Kara
Chief Executive Officer
2024-07-24 19:50:46380,412
45,065
425,477Form 4
Perlysky Dov
Director
2021-01-13 21:40:47335,780
0
335,780Form 4
TAGLIAFERRI MARY
Director
2024-02-02 21:01:32312,383
0
312,383Form 4
Bench David
Chief Financial Officer
2022-06-15 16:31:04285,800
10,138
295,938Form 4
BORTZ GREGORY M.
Director
2019-01-18 16:30:27269,045
0
269,045Form 4
KASTEN BERNARD L
Director
2016-03-18 14:41:47257,455
0
257,455Form 4
ENGELHARDT DEAN
Executive Vice President
2007-02-09 12:45:50240,655
0
240,655Form 4
SIAS JOHN B
Director
2008-10-01 08:39:36173,087
0
173,087Form 4
Fischer Rebecca J.
Director
2021-01-13 21:43:13160,434
0
160,434Form 4
Walters Ian B.
Director
2023-02-13 21:40:36155,917
0
155,917Form 4
KELKER NORMAN E
Senior Vice President
2008-09-25 21:12:01110,855
0
110,855Form 4
Eckert Patricia
Chief Financial Officer
2024-07-25 17:23:16100,000
0
100,000Form 4
PULLY STEVEN J
Director
2024-02-02 21:02:1097,095
0
97,095Form 4
DELUCCA JOHN
Director
2008-01-16 20:58:5783,647
0
83,647Form 4
CLEMENS PETER J IV
Director
2020-04-29 20:06:1983,333
0
83,333Form 4/A
BLANK FABIAN
Director
2020-04-29 20:19:5583,333
0
83,333Form 4
Kent Stephen B H
Director
2012-01-30 20:42:2758,532
0
58,532Form 4
THALENFELD BARBARA E
VP, Corporate Development
2008-02-06 19:36:4455,550
0
55,550Form 4
GOLDBERG DAVID C
VP CorpDev IGM Enz Clin Labs
2016-03-16 16:37:0647,455
0
47,455Form 4
Hanna Bruce A.
Director
2019-01-04 16:52:3443,632
0
43,632Form 4
O'Brien James Michael
EVP of Finance
2019-01-04 17:02:2533,666
0
33,666Form 4
GERSON IRWIN
Director
2010-03-08 16:56:3031,191
0
31,191Form 4
LAZAR MELVIN F
Director
2010-03-08 16:56:0031,191
0
31,191Form 4
Crescenzo Andrew R.
Senior VP of Finance
2014-01-22 16:57:4929,455
0
29,455Form 4
BALEZENTIS CARL W
Pres., Enzo Life Sciences
2010-12-20 18:13:5225,950
0
25,950Form 4
Conant Marcus
Director
2004-07-19 11:08:2225,198
0
25,198Form 3
KRENITSKY KEVIN
President, Enzo Clinical Labs
2010-02-02 20:15:2817,600
0
17,600Form 4
BASS HERBERT B
VP of Finance
2014-01-22 17:05:4412,273
0
12,273Form 4
Whiteley Andrew P
COO, Enzo Life Sciences, Inc.
2014-01-22 17:04:4112,273
0
12,273Form 4
FISCHETTE CHRISTINE
Pres., Enzo Therapeutics, Inc.
2009-01-26 21:22:4011,500
0
11,500Form 4
WARSHAWSKY STANFORD S
01/2004, Resigned as Director
2004-05-19 17:42:350
0
0Form 4